Unknown PHASE2 INTERVENTIONAL 2-arm NCT02335281

Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease (SFMT-IBD)

Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation for Severe Inflammatory Bowel Disease

Sponsor: Yanling Wei

Conditions Crohn's Disease Inflammatory Bowel Disease Ulcerative Colitis

Updated 6 times since 2017 Last updated: Jan 8, 2015 Started: Jan 31, 2015 Primary completion: Oct 31, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Crohn's Disease and Inflammatory Bowel Disease and is currently ongoing. Yanling Wei leads this study, which shows 6 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2018 [monthly]

Recruiting PHASE2

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yanling Wei

Data source: Third Military Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Chongqing, China